Literature DB >> 3261968

Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.

M M O'Sullivan1, N Amos, B D Williams.   

Abstract

Serum samples from patients with seropositive rheumatoid arthritis contain an inhibitor of complement mediated inhibition of immune precipitation (CMIP). This inhibitory effect can be produced by the addition of either purified monoclonal or polyclonal IgM rheumatoid factor (RF) to human serum. The specificity of the rheumatoid factor influences the degree of inhibition, and when precipitation occurs the rheumatoid factor coprecipitates with the antigen-antibody complex. In rheumatoid sera there was a significant positive correlation between IgM RF concentration and inhibitory activity, though the range of inhibitory activity seen for the same concentration of rheumatoid factor was considerable. Small quantities of heat aggregated IgG (HAGG) had a much greater effect on the measurement in an enzyme linked immunosorbent assay (ELISA) of IgM RF than they did on the inhibitory activity of IgM RF in the CMIP assay. Larger quantities of HAGG initiated complement activation and increased the precipitation of immune complexes. IgM RF reduced the complement activating properties of HAGG by reducing the amount of Clq which bound to the aggregate. The mechanisms by which IgM RF overcomes CMIP in rheumatoid sera may involve its inhibitory effects on the binding of Cl to the antigen-antibody complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261968      PMCID: PMC1006721          DOI: 10.1136/ard.47.8.675

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  FURTHER STUDIES OF AN INHIBITOR OF THE TWO ANTIBODY IMMUNOASSAY SYSTEM.

Authors:  C R MORGAN; R L SORENSON; A LAZAROW
Journal:  Diabetes       Date:  1964 Nov-Dec       Impact factor: 9.461

2.  Observations on the precipitation reaction in a double-antibody immunoassay for insulin.

Authors:  D B Grant
Journal:  Acta Endocrinol (Copenh)       Date:  1968-09

3.  Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies.

Authors:  N J Zvaifler; P Schur
Journal:  Arthritis Rheum       Date:  1968-08

4.  Catalysis of iodination by lactoperoxidase.

Authors:  M Morrison; G S Bayse
Journal:  Biochemistry       Date:  1970-07-21       Impact factor: 3.162

5.  Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4.

Authors:  U K Sabharwal; J H Vaughan; S Fong; P H Bennett; D A Carson; J G Curd
Journal:  Arthritis Rheum       Date:  1982-02

6.  Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.

Authors:  J K Naama; W S Mitchell; A Zoma; J Veitch; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  IgM-RF prevents complement-mediated inhibition of immune precipitation.

Authors:  W S Mitchell; J K Naama; J Veitch; K Whaley
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

8.  Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.

Authors:  J K Naama; W S Mitchell; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  3 in total

1.  Immunoglobulin G structure and rheumatoid factor epitopes.

Authors:  Sheila Lefoli Maibom-Thomsen; Nicole Hartwig Trier; Bettina Eide Holm; Kirsten Beth Hansen; Morten Ib Rasmussen; Anna Chailyan; Paolo Marcatili; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

2.  Complement-mediated inhibition of immune precipitation in rheumatoid vasculitis.

Authors:  M M O'Sullivan; N Amos; A Bedwell; B D Williams
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA).

Authors:  J N Jarvis; M M Diebold; M K Chadwell; M Iobidze; H T Moore
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.